Mortality and adverse events of special interest with intravenous belimumab for adults with active, autoantibody-positive systemic lupus erythematosus (BASE): a multicentre, double-blind, randomised, placebo-controlled, phase 4 trial

Saira Z. Sheikh, Morton Scheinberg, James Cheng‐Chung Wei, Dana Tegzová, William Stohl, Ricardo Acayaba de Toledo, Tamara Mucenic, Mauricio R Abello Banfi, Kathleen Maksimowicz‐McKinnon, Carlos Abud‐Mendoza, Sandra Navarra, Mercedes García, Ignacio Garcı́a-De La Torre, Josep Ros, Roger A. Levy, Damon Bass, Jorge Ross Terrés, Raj Punwaney, Julia Harris, Alireza Nami, Amy Pierce, Kevin S. Thorneloe, Beulah Ji, David A. Roth